Todd E Defor


Ontology type: schema:Person     


Person Info

NAME

Todd E

SURNAME

Defor

Publications in SciGraph latest 50 shown

  • 2018-11-13 Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid in MODERN PATHOLOGY
  • 2018-03 Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2018-01 Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation in BONE MARROW TRANSPLANTATION
  • 2018-01 Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402 in BONE MARROW TRANSPLANTATION
  • 2017-09 Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402 in BONE MARROW TRANSPLANTATION
  • 2017-04 MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes in BONE MARROW TRANSPLANTATION
  • 2017-02 Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2016-10 Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning in BONE MARROW TRANSPLANTATION
  • 2016-02 CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT in LEUKEMIA
  • 2016-02 Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome in BONE MARROW TRANSPLANTATION
  • 2015-12 Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment in SPRINGERPLUS
  • 2014-12 The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML in BONE MARROW TRANSPLANTATION
  • 2014-01 Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival in BONE MARROW TRANSPLANTATION
  • 2013-11 Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML in BONE MARROW TRANSPLANTATION
  • 2013-11 Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML in BONE MARROW TRANSPLANTATION
  • 2013-11 Transient regulatory T-cell (Treg) depletion with IL-2 diphtheria toxin fusion protein enhances clearance of acute myeloid leukemia by haploidentical natural killer (NK) cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-05 CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation in LEUKEMIA
  • 2012-06 Factors predicting single-unit predominance after double umbilical cord blood transplantation in BONE MARROW TRANSPLANTATION
  • 2012-04 Three-dimensional patient setup errors at different treatment sites measured by the Tomotherapy megavoltage CT in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2011-07 Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival in BONE MARROW TRANSPLANTATION
  • 2010-07 Pre-transplant risk factors affecting outcome in Hurler syndrome in BONE MARROW TRANSPLANTATION
  • 2010-05 Characterization and management of hypercalcemia following transplantation for osteopetrosis in BONE MARROW TRANSPLANTATION
  • 2010-05 A modified comorbidity index for hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2009-07 Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2009-06 Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units in BONE MARROW TRANSPLANTATION
  • 2009-03 Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial in BONE MARROW TRANSPLANTATION
  • 2009-02 Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma in BONE MARROW TRANSPLANTATION
  • 2009-01 New classification of chronic GVHD: added clarity from the consensus diagnoses in BONE MARROW TRANSPLANTATION
  • 2007-02 Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial in BONE MARROW TRANSPLANTATION
  • 2006-12 Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioning in BONE MARROW TRANSPLANTATION
  • 2006-01 Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors in BONE MARROW TRANSPLANTATION
  • 2005-06 Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma in BONE MARROW TRANSPLANTATION
  • 2003-09 Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood in BONE MARROW TRANSPLANTATION
  • 2003-07 IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial in BONE MARROW TRANSPLANTATION
  • 2002-12 Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation in BONE MARROW TRANSPLANTATION
  • 2002-03 Outcome of second hematopoietic cell transplantation in Hurler syndrome in BONE MARROW TRANSPLANTATION
  • 2001-04 Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2000-10 Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation in BONE MARROW TRANSPLANTATION
  • 2000-10 Response to thalidomide therapy in refractory chronic graft-versus-host disease in BONE MARROW TRANSPLANTATION
  • 2000-09 Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy in BONE MARROW TRANSPLANTATION
  • 2000-09 Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia in BONE MARROW TRANSPLANTATION
  • 2000-04 Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • 2000-02 Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 1999-09 Autologous stem cell transplantation for high-risk pediatric solid tumors in BONE MARROW TRANSPLANTATION
  • 1999-06 High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths in BONE MARROW TRANSPLANTATION
  • 1999-02 B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome in BONE MARROW TRANSPLANTATION
  • 1999-01 Risk factors for severe hemorrhagic cystitis following BMT in BONE MARROW TRANSPLANTATION
  • 1998-01 Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis in BONE MARROW TRANSPLANTATION
  • 1997-09 ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival in ANNALS OF HEMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.17635.36", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.266813.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416201.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.224260.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411111.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Defor", 
        "givenName": "Todd E", 
        "id": "sg:person.0726643327.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726643327.55"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_528.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0726643327.55'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0726643327.55'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0726643327.55'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0726643327.55'


     

    This table displays all metadata directly associated to this object as RDF triples.

    24 TRIPLES      10 PREDICATES      15 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0726643327.55 schema:affiliation N6082d248e6e2471cbe82907ee0f242c5
    2 https://www.grid.ac/institutes/grid.224260.0
    3 https://www.grid.ac/institutes/grid.266813.8
    4 https://www.grid.ac/institutes/grid.411111.5
    5 https://www.grid.ac/institutes/grid.416201.0
    6 schema:familyName Defor
    7 schema:givenName Todd E
    8 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726643327.55
    9 schema:sdDatePublished 2019-03-07T14:47
    10 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    11 schema:sdPublisher N9b9e2b8d6b8e42b4a9df14e8844c1b77
    12 sgo:license sg:explorer/license/
    13 sgo:sdDataset persons
    14 rdf:type schema:Person
    15 N6082d248e6e2471cbe82907ee0f242c5 schema:affiliation https://www.grid.ac/institutes/grid.17635.36
    16 sgo:isCurrent true
    17 rdf:type schema:OrganizationRole
    18 N9b9e2b8d6b8e42b4a9df14e8844c1b77 schema:name Springer Nature - SN SciGraph project
    19 rdf:type schema:Organization
    20 https://www.grid.ac/institutes/grid.17635.36 schema:Organization
    21 https://www.grid.ac/institutes/grid.224260.0 schema:Organization
    22 https://www.grid.ac/institutes/grid.266813.8 schema:Organization
    23 https://www.grid.ac/institutes/grid.411111.5 schema:Organization
    24 https://www.grid.ac/institutes/grid.416201.0 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...